logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
D

David Tougeron

centre hospitalier universitaire de poitiers

51H指数
502论文数
1.1W被引数
收录论文 218
发表时间
logo
First-Line Fluoropyrimidine- versus Gemcitabine-Based Chemotherapy for Metastatic Recurrence After Resection of Ampullary Adenocarcinoma: a Real-World Analysis of the FFCD-AC Cohort壶腹腺癌切除术后转移性复发的氟嘧啶类与吉西他滨为基础的化疗比较：FFCD-AC队列的真实世界分析
errEuropean Journal of Cancer
IF7.1
err2026-10-09
err0
PREAI
errErwan Vo-Quang; Vincent Hautefeuille; Olivier Bouché; Karine Le Malicot; David Tougeron; Stéphanie Truant; Anna Pellat; Morgane Amil; Gael Roth; Marine Jary; Sylvain Manfredi; Marielle Guillet; Olivier Glehen; Julien Taieb; Claire Gallois
err分享
err收藏
Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203): a phase II study奥昔帕利单抗和替雷利珠单抗在晚期食管鳞状细胞癌中的应用（AdvanTIG-203）：一项II期研究
errNature Communications
IF15.7
err2026-09-18
err0
errOAAI
errFeng Wang; Chen-Yuan Lin; Jong-Mu Sun; Chang-Hsien Lu; Xueqiang Zhu; Zhendong Chen; Qi Zhao; In-Ho Kim; Yueyin Pan; Jingdong Zhang; Zhaohong Chen; David Tougeron; Sung-Bae Kim; Eric Van Cutsem; Aziz Zaanan; Fernando Rivera; Arunee Dechaphunkul; Yunxia Zuo; Qiting Wan; Juan Zhang; Jiadong Zhou; Rui-Hua Xu
err分享
err收藏
First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306)一线替雷利珠单抗联合化疗对比安慰剂联合化疗在不可切除的局部晚期/转移性食管鳞状细胞癌中的应用：一项随机III期试验（RATIONALE-306）3年生存随访的最低数据
errNature Communications
IF15.7
err2026-09-03
err0
errOAAI
errHarry H. Yoon; Ken Kato; Eric Raymond; Richard Hubner; Yongqian Shu; Yueyin Pan; Sook Ryun Park; Takashi Kojima; Chen-Yuan Lin; Lucjan Wyrwicz; David Tougeron; Ryu Ishihara; Kaijun Wang; Yanyan Peng; Jianming Xu
err分享
err收藏
Interpretable AIto predict anal cancer local failure at 3 years with the FFCD Anabase prospective multicentric cohort可解释AI预测FFCD Anabase前瞻性多中心队列中3年肛门癌局部复发
errRadiotherapy and Oncology
IF5.3
err2026-08-01
err0
PREAI
errRaynaud, C.; Vendrely, V.; Quero, L.; Lemanski, C.; Pommier, P.; Le Malicot, K.; Saint, A.; Del Campo, E. Rivin; Regnault, P.; Baba-Hamed, N.; Ronchin, P.; Crehange, G.; Tougeron, D.; Menager-Tabourel, E.; Diaz, O.; Hummelsberger, M.; Minsat, M.; Drouet, F.; Larrouy, A.; Peiffert, D.; Lievre, A.; Zasadny, X.; Hautefeuille, V.; Mornex, F.; Lepage, C.; Bibault, J. -E.
err分享
err收藏
Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort)
errJHEP Reports
IF7.5
err2026-07-28
err0
errOAAI
errClaire Noé; Julie Henriques; Brice Chanez; Dewi Vernerey; Thierry Lecomte; Alice Durand; Eric Assenat; Julien Edeline; Alexandra Heurgué; David Tougeron; Sylvain Manfredi; Vincent Hautefeuille; Cindy Neuzillet; Gaël Roth; Jean-Paul Lagasse; Christophe Tournigand; Matthieu Delaye; Antoine Hollebecque; Anthony Turpin; Pauline Parent
err分享
err收藏
Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy局部晚期直肠癌患者接受总新辅助治疗后出现错配修复缺陷或微卫星不稳定性
errEuropean Journal of Cancer
IF7.1
err2026-07-02
err0
PREAI
errNada Benhima; Alessandro Audisio; Chiara Gallio; Gianluca Ricco; Hélène Meillat; Vaneja Velenik; Maria Carmen Riesco; Javier Suárez Alecha; Gertjan Rasschaert; David Páez López-Bravo; David Tougeron; Carlos Carvalho; Beatrice Borelli; Federico Famiglietti; Carolina De la Pinta; Juan Manuel O’Connor; Mehmet Artaç; Pètra M. Braam; Alberto Puccini; Ithai Waldhorn
err分享
err收藏
Sequential alternation of nal-IRI/5-FU and gemcitabine/nab-paclitaxel versus nal-IRI/5-FU versus gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer: results of the randomized phase II PRODIGE 61—FUNGEMAX trial (France)纳曲伊立替康/5-氟尿嘧啶与吉西他滨/阿帕他汀相比纳曲伊立替康/5-氟尿嘧啶与吉西他滨/阿帕他汀在一线转移性胰腺癌中的序贯交替方案：法国随机II期PRODIGE 61—FUNGEMAX试验结果
errEClinicalMedicine
IF10
err2026-05-29
err0
errOAAI
errJulien Taieb; Simon Pernot; Frédéric Thuillier; Alexis Delattre; Erwan Vo-Quang; Caroline Petorin; Vincent Bourgeois; David Tougeron; Franck Audemar; Carole Vitellius; Laurent Mosser; Jérôme Desrame; Frédéric Di Fiore; Yves Rinaldi; Anna Pellat; Marion Bolliet; Fabienne Watelle; Hervé Perrier; Olivier Dubreuil; Come Lepage
err分享
err收藏
FRUQUITAS trial: Study design of an ENGIC intergroup randomized phase III of trifluridine/tipiracil +/- fruquintinib in pre-treated metastatic gastro-oesophageal adenocarcinomaFRUQUITAS试验：三氟尿idine/替匹拉西布联合/不联合 fruquintinib治疗经治转移性胃食管腺癌的ENGIC协作组随机III期研究设计
errDigestive and Liver Disease
IF3.8
err2026-05-09
err0
errOAAI
errDavid Tougeron; Fernando Rivera; Tania Fleitas Kanonnikoff; Karine Le Malicot; Meriem Guarssifi; Nadim Fares; Emilie Soularue; Melanie Dos Santos; Mathilde Wagner; Julien Taieb; Thomas Aparicio; Pierre Laurent-Puig; Ulrich T. Hacker; Ana Fernández Montes; Salah-Eddin Al-Batran; Florian Lordick
err分享
err收藏
Mucinous histology and resistance to immune checkpoint blockade in patients with microsatellite instability-high metastatic colorectal cancer黏液性组织学与微卫星不稳定性高转移性结直肠癌患者对免疫检查点阻断的抵抗
errThe Oncologist
IF0
err2026-05-01
err0
errOAAI
errVincenzo Nasca; Margherita Ambrosini; Julien Taieb; Romain Cohen; Sara Lonardi; Ben Boursi; Ofer Margalit; Lisa Salvatore; Javier Ros; Giovanna Sabella; Chiara Rossi; David Tougeron; Rosine Guimbaud; Claire Gallois; Maria Elena Elez; Francesca Bergamo; Chiara Cremolini; Michael J Overman; Thierry André; Giovanni Randon; Filippo Pietrantonio
err分享
err收藏
From clusters to clinic: an 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer从簇到临床：一个8基因签名与黏液性成分相结合，可分层评估在dMMR/MSI-H转移性结直肠癌中添加抗CTLA-4治疗相对于抗PD-1治疗的获益。
errEuropean Journal of Cancer
IF7.1
err2026-04-05
err0
errOAAI
errMargherita Ambrosini; Claire Gallois; Annalice Gandini; Aurélie Lecanu; Emily Alouani; Filippo Pietrantonio; Francesca Bergamo; Chiara Cremolini; Thibault Mazard; David Tougeron; Rosine Guimbaud; Sara Lonardi; Janick Selves; Sophie Mouillet-Richard; Jean-Francois Emile; Julien Taieb; Pierre Laurent-Puig
err分享
err收藏
Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: a retrospective study by AGEO靶向疗法治疗转移性小肠腺癌的疗效：AGEO进行的一项回顾性研究
errEuropean Journal of Cancer
IF7.1
err2026-03-28
err0
PREAI
errEmeric Boisteau; Alice Boilève; David Tougeron; Dewi Vernerey; Alice De Malet; Thierry Lecomte; Thomas Aparicio; Simon Pernot; Julien Pinot; Anna Pellat; Vincent Hautefeuille; Nadim Farès; Romain Desgrippes; Romain Coriat; Aziz Zaanan; Julien Edeline; Sara Philonenko; Olivier Dubreuil; Julie Henriques; Anthony Turpin
err分享
err收藏
Analysis of diagnostic pathway and therapeutic delay for patients with pancreatic adenocarcinoma: a French retrospective study胰腺腺癌患者诊断路径和治疗延迟的分析：一项法国回顾性研究
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-03-11
err0
PREAI
errCamille Evrard; Bérénice Vauchel; Claire Boyer; Aurélie Ferru; Raphael Olivier; David Tougeron
err分享
err收藏
Compound Heterozygous Complete Loss-of-Function SPINK1 Variants as a Novel Cause of Severe Infantile Isolated Exocrine Pancreatic Insufficiency复合杂合完全失活SPINK1变异作为严重婴儿孤立性外分泌胰腺功能不全的一种新型病因
errGenes
IF2.8
err2026-03-03
err0
errOAAI
errEmmanuelle Masson; Marc Wangermez; David Tougeron; Vinciane Rebours; Claude Férec; Jian-Min Chen
err分享
err收藏
Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: An international multicenter analysis from the AGEO group
errCLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
IF2.4
err2026-01-01
err0
errOAAI
errGandini, Annalice; Probst, Victoria; Landi, Matteo; Grandis, Maria Caterina De; Cremolini, Chiara; Lonardi, Sara; Girot, Paul; Decraecker, Marie; Passardi, Alessandro; Salvatore, Lisa; Pastorino, Alessandro; Jones, Jeremy C.; Grados, Lucien; Sayah, Lina; Trouilloud, Isabelle; Tougeron, David; Taieb, Julien
err分享
err收藏
Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES)新辅助帕博利珠单抗联合观察等待策略治疗局部MSI/dMMR结直肠癌：一项随机GERCOR 109 – PRODIGE 84期II临床试验（PREMICES）的研究方案
errDigestive and Liver Disease
IF3.8
err2025-11-22
err0
errOAAI
errJérémie H. Lefevre; Olivier Dubreuil; Raphael Colle; David Tougeron; Angélique Vienot; Aurélien Dupré; Clémence Toullec; Denis Smith; Rosine Guimbaud; Benoist Chibaudel; Marie-Line Garcia Larnicol; Dewi Vernerey; Romain Cohen
err分享
err收藏
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: a pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)抗EGFR抗体与抗VEGF抗体在BRAFV600E突变型转移性结直肠癌中根据原发肿瘤侧性的初始治疗疗效：一项在mCRC初始治疗中进行的七项临床试验的合并分析（德国AIO研究组）
errEuropean Journal of Cancer
IF7.1
err2025-11-13
err0
errOAAI
errLena Weiss; Sebastian Stintzing; Dominik Paul Modest; Arndt Stahler; Ludwig Fischer von Weikersthal; Anke Reinacher-Schick; Thomas Decker; Victoria Probst; Kathrin Heinrich; Ingo Schwaner; Florian Kaiser; Rudolf Pihusch; Martin Fuchs; Swantje Held; Annabel Alig; Birgit Gruenberger; Gerald Werner Prager; David Tougeron; Julien Taieb; Volker Heinemann
err分享
err收藏
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trialEzabenlimab与诱导化疗，随后进行适应性放化疗，用于III期鳞状细胞肛管癌患者的治疗（INTERACT-ION）：一项开放标签、单臂、II期临床试验
errThe Lancet Oncology
IF0
err2025-11-04
err0
errOAAI
errStefano Kim; Jihane Boustani; Soledad Iseas; Dewi Vernerey; Ludovic Evesque; Laurent Quero; Francois Ghiringhelli; Clélia Coutzac; Olivier Bouché; Benoist Chibaudel; Chloé Vernet; Angélique Vienot; David Tougeron; Thierry Nguyen; Magali Rebucci-Peixoto; Aurélia Meurisse; Sarah Chennoufi; Christophe Maritaz; Christophe Borg
err分享
err收藏
Impact of next-generation sequencing on routine clinical practice and patient inclusion in molecularly targeted clinical trials: a retrospective cohort analysis下一代测序对常规临床实践和患者纳入分子靶向临床 trial 的影响：一项回顾性队列分析
errClinical and Translational Oncology
IF2.5
err2025-10-29
err0
errOAAI
errMathieu Faigner; Lucie Karayan-Tapon; Ulrich Cortes; Birama Ndiaye; Marine Martel; Pierre Rivet; Jade Duche; Nicolas Isambert; David Tougeron; Camille Evrard
err分享
err收藏
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)老年患者胆道肿瘤的管理：一项法国多中心回顾性研究（PRONOBIL-ACABi）
errTherapeutic Advances in Medical Oncology
IF4.2
err2025-10-03
err0
errOAAI
errMarine Valery; Julien Edeline; Julie Henriques; Leony Antoun; Heloise Bourien; Antoine Lebeaud; Nadim Fares; Christophe Tournigand; Thierry Lecomte; David Tougeron; Vincent Hautefeuille; Angelique Vienot; Nicolas Williet; Jean-Baptiste Bachet; David Malka; Cristina Smolenschi; Antoine Hollebecque; Jane-Rose Paccard; Maxime Frélaut; Pascal Hammel; Anthony Turpin; Alice Boileve
err分享
err收藏
First-line PD-1+/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer一线PD-1+/−联合CTLA-4阻断治疗错配修复缺陷和/或微卫星高度不稳定转移性结直肠癌患者
errONCOLOGIST
IF4.2
err2025-09-01
err1
errOAAI
errNasca, Vincenzo; Tine, Gabriele; Taieb, Julien; Lonardi, Sara; Boursi, Ben; Margalit, Ofer; Salvatore, Lisa; Cohen, Romain; Ros, Javier; Ambrosini, Margherita; Zwart, Koen; Roodhart, Jeanine; Jayachandran, Priya; Overman, Michael J.; Elez, Maria Elena; Cremolini, Chiara; Tougeron, David; Koopman, Miriam; Andre, Thierry; Miceli, Rosalba; Pietrantonio, Filippo
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Eric Van Cutsem
H 指数: 174 · 论文数: 1.8K
J
Jean‐Yves Blay
H 指数: 158 · 论文数: 2.4K
S
Stephen N. Thibodeau
H 指数: 119 · 论文数: 815
H
Howard A. Burris
H 指数: 117 · 论文数: 1.1K
É
Éric Baudin
H 指数: 116 · 论文数: 680
查看更多